(Total Views: 909)
Posted On: 06/27/2020 10:46:17 PM
Post# of 149265
From yahoo gonna be 4/5 posts after this one
Hi I am trying to figure out cost of sales... also how leronlimab got its pricing per dose...
From the 10k (annual report) it looks like 5% of net sales go to Progenics. And 2% to “Lonza Agreement”, and 3.5% to AbbVie, most of which last for 10 years.
The agreement with Samsung requires a $30 million (!) payment in 2020 alone.
Not to mention a 50% marketing agreement with Vyera for HIV at least.
But I have no idea what manufacture of leronlimb costs per dose. Also I have seen $2k per dose, if I recall, but no idea how CYDY selected that price.
Does anyone have more concrete info on cost of manufacture, other per-unit costs, and how Cytodyn selected its per-unit price? Can they choose whatever price the market will bear, or does that involve FDA or other agencies? Trying to understand profit potential vs gross sales.
Hi I am trying to figure out cost of sales... also how leronlimab got its pricing per dose...
From the 10k (annual report) it looks like 5% of net sales go to Progenics. And 2% to “Lonza Agreement”, and 3.5% to AbbVie, most of which last for 10 years.
The agreement with Samsung requires a $30 million (!) payment in 2020 alone.
Not to mention a 50% marketing agreement with Vyera for HIV at least.
But I have no idea what manufacture of leronlimb costs per dose. Also I have seen $2k per dose, if I recall, but no idea how CYDY selected that price.
Does anyone have more concrete info on cost of manufacture, other per-unit costs, and how Cytodyn selected its per-unit price? Can they choose whatever price the market will bear, or does that involve FDA or other agencies? Trying to understand profit potential vs gross sales.
(0)
(0)Scroll down for more posts ▼
